Pages that link to "Q28254452"
Jump to navigation
Jump to search
The following pages link to Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency (Q28254452):
Displaying 50 items.
- Progressive familial intrahepatic cholestasis (Q21202893) (← links)
- Bile acids as endogenous etiologic agents in gastrointestinal cancer (Q22305504) (← links)
- Cholestatic liver disease in children (Q24598006) (← links)
- Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression (Q24617391) (← links)
- Bile acid transporters (Q24652624) (← links)
- Liver transplantation and the management of progressive familial intrahepatic cholestasis in children (Q26745970) (← links)
- Liver tumors in children with metabolic disorders (Q26770292) (← links)
- Liver biopsy in modern clinical practice: a pediatric point-of-view (Q26826920) (← links)
- Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing (Q28304808) (← links)
- Mechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor (Q30409833) (← links)
- Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma (Q30414018) (← links)
- A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults (Q33368134) (← links)
- Bile composition in Alagille Syndrome and PFIC patients having Partial External Biliary Diversion (Q33378260) (← links)
- Pancreatic adenocarcinoma in type 2 progressive familial intrahepatic cholestasis (Q33540358) (← links)
- Progressive familial intrahepatic cholestasis. (Q33595403) (← links)
- Clinical application of transcriptional activators of bile salt transporters (Q33709930) (← links)
- Xenobiotic, bile acid, and cholesterol transporters: function and regulation. (Q33714593) (← links)
- Clinical Applicability of Whole-Exome Sequencing Exemplified by a Study in Young Adults with the Advanced Cryptogenic Cholestatic Liver Diseases. (Q33775587) (← links)
- Hepatocyte transplantation in bile salt export pump-deficient mice: selective growth advantage of donor hepatocytes under bile acid stress. (Q33985967) (← links)
- Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma (Q34224637) (← links)
- The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease (Q34432666) (← links)
- Differences in presentation and progression between severe FIC1 and BSEP deficiencies (Q34592094) (← links)
- Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice (Q35077956) (← links)
- Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family (Q35124972) (← links)
- Hereditary pancreatic and hepatobiliary cancers (Q35692230) (← links)
- A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis (Q35871064) (← links)
- Approach to a patient with elevated serum alkaline phosphatase (Q35926418) (← links)
- RNA-Seq reveals different mRNA abundance of transporters and their alternative transcript isoforms during liver development (Q35969277) (← links)
- Bile acids via FXR initiate the expression of major transporters involved in the enterohepatic circulation of bile acids in newborn mice. (Q35994016) (← links)
- FXR and liver carcinogenesis (Q36063712) (← links)
- Structural and functional hepatocyte polarity and liver disease (Q36090717) (← links)
- Abcb11 deficiency induces cholestasis coupled to impaired β-fatty acid oxidation in mice (Q36098104) (← links)
- Morphologic findings in progressive familial intrahepatic cholestasis 2 (PFIC2): correlation with genetic and immunohistochemical studies (Q36154600) (← links)
- Hepatocellular carcinoma associated with tight-junction protein 2 deficiency (Q36225908) (← links)
- Bile Acid Receptors and Liver Cancer (Q36607910) (← links)
- Nuclear receptors as drug targets in cholestatic liver diseases (Q36786270) (← links)
- Xenobiotic transporters: ascribing function from gene knockout and mutation studies (Q36910081) (← links)
- Clinical and ABCB11 profiles in Korean infants with progressive familial intrahepatic cholestasis (Q36919455) (← links)
- Genetic factors in the pathogenesis of cholangiocarcinoma (Q36966040) (← links)
- Congenital cholestatic syndromes: what happens when children grow up? (Q37008383) (← links)
- Liver repopulation and carcinogenesis: two sides of the same coin? (Q37102829) (← links)
- Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling (Q37139504) (← links)
- Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations (Q37200971) (← links)
- OST alpha-OST beta: a key membrane transporter of bile acids and conjugated steroids (Q37222442) (← links)
- Endocrine and paracrine role of bile acids (Q37287593) (← links)
- Novel ABCB11 mutations in a Thai infant with progressive familial intrahepatic cholestasis (Q37347363) (← links)
- Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report. (Q37444723) (← links)
- Increased hepatocellular carcinoma risk in chronic hepatitis B patients with persistently elevated serum total bile acid: a retrospective cohort study (Q37460011) (← links)
- Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer (Q37537548) (← links)
- Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cells (Q37620655) (← links)